SE398645B - Analogiforfarande for framstellning av kondenserade indolforeningar - Google Patents
Analogiforfarande for framstellning av kondenserade indolforeningarInfo
- Publication number
- SE398645B SE398645B SE7200278A SE27872A SE398645B SE 398645 B SE398645 B SE 398645B SE 7200278 A SE7200278 A SE 7200278A SE 27872 A SE27872 A SE 27872A SE 398645 B SE398645 B SE 398645B
- Authority
- SE
- Sweden
- Prior art keywords
- associations
- preparing condensed
- condensed indole
- analogical procedure
- analogical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB125071*[A GB1366133A (en) | 1971-01-11 | 1971-01-11 | Fused ring indole derivatives |
| GB4095971 | 1971-09-02 | ||
| GB5646771 | 1971-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE398645B true SE398645B (sv) | 1978-01-09 |
Family
ID=27253859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7200278A SE398645B (sv) | 1971-01-11 | 1972-01-11 | Analogiforfarande for framstellning av kondenserade indolforeningar |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS5531156B2 (de) |
| AR (1) | AR192734A1 (de) |
| AT (1) | AT312595B (de) |
| AU (1) | AU464388B2 (de) |
| BE (1) | BE777911A (de) |
| CA (1) | CA1012150A (de) |
| CH (1) | CH573938A5 (de) |
| CY (1) | CY926A (de) |
| DK (1) | DK150143C (de) |
| EG (1) | EG10888A (de) |
| ES (2) | ES398678A1 (de) |
| FI (1) | FI54120C (de) |
| FR (1) | FR2121699B1 (de) |
| GB (1) | GB1366133A (de) |
| HK (1) | HK52877A (de) |
| IE (1) | IE35956B1 (de) |
| KE (1) | KE2777A (de) |
| MY (1) | MY7800048A (de) |
| NL (1) | NL174251C (de) |
| SE (1) | SE398645B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1520611A (en) * | 1976-06-11 | 1978-08-09 | Wyeth John & Brother Ltd | Fused ring indole derivatives |
| JPS5845741B2 (ja) * | 1977-06-06 | 1983-10-12 | 株式会社日立製作所 | 情報検索装置 |
| ZA824382B (en) * | 1981-07-07 | 1984-02-29 | Wyeth John & Brother Ltd | Anti-obesity agents |
| JPS60204057A (ja) * | 1984-03-28 | 1985-10-15 | Casio Comput Co Ltd | デ−タ記憶機能付小型電子機器 |
| GB8606253D0 (en) * | 1986-03-13 | 1986-04-16 | Wyeth John & Brother Ltd | Pyrimidoindoles |
| GB8606254D0 (en) * | 1986-03-13 | 1986-04-16 | Wyeth John & Brother Ltd | Substituted pyrimidoindoles |
| GB8614246D0 (en) * | 1986-06-11 | 1986-07-16 | Wyeth John & Brother Ltd | Substituted pyrimidoindoles |
| WO2010090680A1 (en) * | 2008-12-15 | 2010-08-12 | Wyeth Llc | Substituted oxindole cb2 agonists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888846A (en) * | 1967-03-30 | 1975-06-10 | Hoffmann La Roche | Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives |
| US3586693A (en) * | 1969-07-07 | 1971-06-22 | American Home Prod | Imidazo(1,2-a)indolin-9-ols |
-
1971
- 1971-01-11 GB GB125071*[A patent/GB1366133A/en not_active Expired
- 1971-12-14 CY CY926A patent/CY926A/xx unknown
-
1972
- 1972-01-04 AU AU37558/72A patent/AU464388B2/en not_active Expired
- 1972-01-05 AT AT7772A patent/AT312595B/de not_active IP Right Cessation
- 1972-01-08 ES ES398678A patent/ES398678A1/es not_active Expired
- 1972-01-08 IE IE14/72A patent/IE35956B1/xx unknown
- 1972-01-09 EG EG12/72A patent/EG10888A/xx active
- 1972-01-10 FR FR7200619A patent/FR2121699B1/fr not_active Expired
- 1972-01-10 DK DK11672A patent/DK150143C/da not_active IP Right Cessation
- 1972-01-10 FI FI45/72A patent/FI54120C/fi active
- 1972-01-10 AR AR240009A patent/AR192734A1/es active
- 1972-01-11 NL NLAANVRAGE7200415,A patent/NL174251C/xx not_active IP Right Cessation
- 1972-01-11 SE SE7200278A patent/SE398645B/xx unknown
- 1972-01-11 JP JP725481A patent/JPS5531156B2/ja not_active Expired
- 1972-01-11 CH CH36472A patent/CH573938A5/xx not_active IP Right Cessation
- 1972-01-11 BE BE777911A patent/BE777911A/xx not_active IP Right Cessation
- 1972-10-26 KE KE2777A patent/KE2777A/xx unknown
- 1972-11-23 CA CA157,326A patent/CA1012150A/en not_active Expired
- 1972-12-05 ES ES409296A patent/ES409296A1/es not_active Expired
-
1977
- 1977-10-13 HK HK528/77A patent/HK52877A/xx unknown
-
1978
- 1978-12-31 MY MY197848A patent/MY7800048A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1012150A (en) | 1977-06-14 |
| NL174251C (nl) | 1984-05-16 |
| CH573938A5 (de) | 1976-03-31 |
| ES409296A1 (es) | 1976-03-16 |
| GB1366133A (en) | 1974-09-11 |
| MY7800048A (en) | 1978-12-31 |
| DK150143C (da) | 1987-06-01 |
| AU3755872A (en) | 1973-07-05 |
| BE777911A (fr) | 1972-07-11 |
| DK150143B (da) | 1986-12-15 |
| NL7200415A (de) | 1972-07-13 |
| KE2777A (en) | 1977-10-21 |
| NL174251B (nl) | 1983-12-16 |
| EG10888A (en) | 1978-06-30 |
| AR192734A1 (es) | 1973-03-14 |
| JPS5531156B2 (de) | 1980-08-15 |
| IE35956B1 (en) | 1976-07-07 |
| AT312595B (de) | 1974-01-10 |
| FI54120C (fi) | 1978-10-10 |
| FR2121699A1 (de) | 1972-08-25 |
| JPS4839500A (de) | 1973-06-09 |
| FR2121699B1 (de) | 1975-08-01 |
| AU464388B2 (en) | 1975-08-28 |
| ES398678A1 (es) | 1975-05-16 |
| CY926A (en) | 1977-12-23 |
| IE35956L (en) | 1972-07-11 |
| HK52877A (en) | 1977-10-20 |
| FI54120B (fi) | 1978-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE393381B (sv) | Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat | |
| SE432102B (sv) | Forfarande for framstellning av estrar av penicilliner | |
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE383358B (sv) | Forfarande for framstellning av pullulan | |
| SE390304B (sv) | Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin | |
| SE406197B (sv) | Analogiforfarande for framstellning av 4-aminokinazolinderivat | |
| SE411755B (sv) | Forfarande for framstellning av n-substituerade 1-aminometylindaner | |
| SE400292B (sv) | Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat | |
| SE398645B (sv) | Analogiforfarande for framstellning av kondenserade indolforeningar | |
| SE395455B (sv) | Forfarande for framstellning av 3-(fenyl-piperazinyl) etylindoliner | |
| SE417711B (sv) | Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat | |
| SE399069B (sv) | Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat | |
| SE393376B (sv) | Forfarande for framstellning av pyrimidinonderivat | |
| SE405478B (sv) | Forfarande for framstellning av alfa-sulfoacylcefalosporiner | |
| SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE386664B (sv) | Forfarande for framstellning av cystinhaltiga peptider | |
| SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
| SE409858B (sv) | Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat | |
| SE387936B (sv) | Forfarande for framstellning av substituerade metoxiaminer | |
| SE394680B (sv) | Forfarande for framstellning av cykliska fosfamidderivat | |
| SE380520B (sv) | Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin | |
| SE7605364L (sv) | Forfarande for framstellning av antracenderivat | |
| SE404803B (sv) | Analogiforfaranden for framstellning av pyrido-diazepiner | |
| SE392902B (sv) | Forfarande for framstellning av fenylimidazolidinoner | |
| SE386897B (sv) | Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler |